Discontinued — last reported Q3 '25
Boston Scientific Finance Lease Liabilities decreased by 37.4% to $122.00M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Higher levels increase the company's long-term leverage and fixed-cost base, while lower levels indicate a more equity-funded or asset-light approach.
The long-term portion of obligations for leases that are classified as financing arrangements, typically involving the e...
Analyzed alongside long-term debt to determine the total contractual leverage and solvency risk of the business.
finance_lease_liabilities| Q3 '25 | Q4 '25 | |
|---|---|---|
| Value | $195.00M | $122.00M |
| QoQ Change | — | -37.4% |